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Abstract
Background: Microbial colonization of the intestine after birth is an important step for the development of the gut
immune system. The acquisition of passive immunity through breast-feeding may influence the pattern of bacterial
colonization in the newborn. The aim of this work was to evaluate the effect of the administration of a probiotic
fermented milk (PFM) containing yogurt starter cultures and the probiotic bacteria strain Lactobacillus casei DN-114001
to mothers during nursing or their offspring, on the intestinal bacterial population and on parameters of the gut immune
system.
Results: Fifteen mice of each group were sacrificed at ages 12, 21, 28 and 45 days. Large intestines were taken for
determination of intestinal microbiota, and small intestines for the study of secretory-IgA (S-IgA) in fluid and the study
of IgA+ cells, macrophages, dendritic cells and goblet cells on tissue samples. The consumption of the PFM either by the
mother during nursing or by the offspring after weaning modified the development of bifidobacteria population in the
large intestine of the mice. These modifications were accompanied with a decrease of enterobacteria population. The
administration of this PFM to the mothers improved their own immune system and this also affected their offspring.
Offspring from mice that received PFM increased S-IgA in intestinal fluids, which mainly originated from their mother's
immune system. A decrease in the number of macrophages, dendritic cells and IgA+ cells during the suckling period in
offspring fed with PFM was observed; this could be related with the improvement of the immunity of the mothers, which
passively protect their babies. At day 45, the mice reach maturity of their own immune system and the effects of the PFM
was the stimulation of their mucosal immunity.
Conclusion: The present work shows the beneficial effect of the administration of a PFM not only to the mothers during
the suckling period but also to their offspring after weaning and until adulthood. This effect positively improved the
intestinal microbiota that are related with a modulation of the gut immune response, which was demonstrated with the
stimulation of the IgA + cells, macrophages and dendritic cells.
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Background
The gastrointestinal tract (GIT) of adult mammals is colo-
nized by a complex and dynamic community of microor-
ganisms in a process of natural selection and ecological
succession. The composition of this microbiota depends
on various factors, some of which are of host origin, such
as the genome and physiology of the animal, whereas oth-
ers are of microbial origin, such as interactions between
bacterial species [1]. After birth, the germ-free human GIT
is rapidly colonized by facultative anaerobic bacteria (e.g.,
Enterobacter) that encourage the growth of anaerobic bac-
teria such as lactobacilli; bifidobacteria; Bacteroides and
clostridia [2,3]. At weaning, with the introduction of solid
food and deprivation of their mother's milk, the young
must also cope with a rapidly changing microbiota. This
is a stress time where, according to Ewing and Cole [4],
numbers of lactobacilli and other beneficial bacteria
could decrease as do their beneficial effects, allowing
potential pathogens such as coliforms to expand.
The resident intestinal microbiota confers many benefits
to the host [5]. Some of these benefits include the metab-
olism of nutrients and organic substrates, and the contri-
bution to the phenomenon of colonization resistance [6].
In experimental studies, the role of the microbiota is
determined by comparing germ free and conventional
animals; newborn germ-free animals exhibit an underde-
veloped intestinal immune system. Experiments using
gnotobiotic animals have shown that association of germ-
free rodents with a single bacterial specie has a profound
impact on the anatomical, physiological, and immuno-
logical development of the host. This includes microbi-
cidal protein production, development of intestinal
epithelium; vasculature and gut associated lymphoid tis-
sue (GALT) [7-9].
The beneficial effects of the microbiota on the immune
system have been proposed as a theory supporting the use
of non pathogenic bacteria, including probiotics in
improving animal health and protection against infec-
tious agents [10]. Probiotics are live microorganisms
which, when administered in adequate amounts confer a
health benefit on the host [11]. These microorganisms can
influence the composition and activity of the gut microbi-
ota, modulate the inflammatory response, improve the
non-specific intestinal barrier, and reinforce or modulate
the mucosal and the systemic immune response [12].
There are many reports about the beneficial effect of the
consumption of fermented milk containing the probiotic
strain  Lactobacillus casei DN-114001 [13-15]. It was
observed that long term fermented milk administration
had immunodulatory effect and maintained the intestinal
homeostasis without adverse secondary effects in mice
[13].
During the early phases of development, neonates
(human or mice) not only rely on their own innate
immune system to help combat infections, they also
acquire adaptive and innate immunity through maternal
sources (via transplacental routes and breast milk), a proc-
ess collectively referred to as passive immunity. Passive
immunity provides a number of defense factors such as
immunoglobulins, lactoferrin, lysozyme, oligosaccha-
rides, cytokines, and chemokines [16,17]. Passive immu-
nity may also influence the development of the systemic
and mucosal adaptive immune system of newborn mice
[18].
The aims of this study was to investigate, using a mouse
model, how the administration of a fermented milk con-
taining the probiotic bacteria L. casei DN-114001, whose
immunomodulatory capacity in adult conventional mice
was demonstrated [13], may affect the composition of the
intestinal bacterial population and influence the intesti-
nal non specific barrier, or the immune cells associated to
the gut, involved in the innate immunity, in newborn
mice before and after weaning. The present study was
designed to evaluate both the consumption of probiotic
fermented milk by the mother and the effect on their off-
spring during the suckling period and the supplementa-
tion to the newborn's diet with this fermented milk after
weaning.
Methods
Animals and protocol design
BALB/c mice used in this study were obtained from the
closed random bred colony maintained at the CERELA
(Centro de Referencia para Lactobacilos, San Miguel de
Tucumán, Argentina). All the animals were fed a conven-
tional balanced diet (23% proteins, 6% raw fiber, 10%
total minerals, 1.3% Ca, 0.8% P, 12% moisture and vita-
mins) ad libitum. Pregnant mice (7 weeks old weighing
25–30 g) were identified and monitored daily until deliv-
ery. The day of birth was identified as day 0 of life. Babies
were weaned at 21 days of age and the study was carried
out until day 45. The experimental protocol contained
two experimental groups of mothers: one receiving the
fermented milk containing the probiotic strain L. casei
DN-114001 (PFM) during the suckling period (B) and the
second did not (A). At weaning, in both groups of moth-
ers, the babies were divided into two subgroups: (b) those
receiving PFM and (a) those that did not. Figure 1
describes the experimental design.
Babies were sacrificed by cervical dislocation at 12, 21, 28
and 45 days of age and samples of small and large intes-
tine were obtained for immunological and microbiologi-
cal studies.BMC Immunology 2008, 9:27 http://www.biomedcentral.com/1471-2172/9/27
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All animal protocols were pre-approved by the Animal
Protection Committee of CERELA and all experiments
comply with the current laws of Argentina.
Fermented milk and feeding procedure
Commercial fermented milk containing the yogurt starter
cultures (L. delbrueckii subsp. bulgaricus 108 CFU/ml and
Streptococcus thermophilus 108 CFU/ml) and the probiotic
bacterium L. casei DN-114 001 (108 CFU/ml) was used in
this study.
Mothers from the test group B received the commercial
product ad libitum during the nursing period. After wean-
ing, according to the protocol detailed above, offspring,
from both A and B groups, received the same PFM or water
continuously until day 45 of age ad libitum. They were the
groups Aa, Ab, Ba and Bb, the first group (Aa) being the
control group with no administration of PFM by the
mothers or their offspring.
Microbiology
The large intestines were aseptically removed, weighed
and placed into sterile tubes containing 5 ml of peptone
water (0.1%). The samples were immediately homoge-
nized under sterile conditions using a homogenizer (MSE,
England). Serial dilutions of the homogenized samples
were obtained and aliquots (0.1 ml) of the appropriate
dilution were spread onto the surface of following agar-
ized media: Reinforced Clostridial (RCA, Britania, Buenos
Aires, Argentina) for total anaerobic bacteria; RCA con-
taining 0.2% LiCl, colistin 4 mg/l, 1% aniline blue and
after sterilization adjusted to pH 5 with acetic acid (RCA-
Design of the different experimental groups under study Figure 1
Design of the different experimental groups under study. Dark gray square are used for the pregnancy period (21 days 
approximately); white square are used for the suckling period (21 days) and light gray square are used for the period after 
weaning (21 days of age) and until adulthood (45 days of age). Arrows indicate the day of the sacrifice (12, 21, 28 and 45 after 
birth). Brackets are used to indicate the periods where the mothers or their offspring receive the PFM.
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pH5) for isolation of bifidobacteria; Mann-Rogosa-Sharp
Agar (MRS Britania, Buenos Aires, Argentina) for total
lactobacilli; M-17 with colistin 4 mg/l (Difco, Elancourt,
France) for lactic flora and Mac Conkey (Britania, Buenos
Aires, Argentina) for Enterobacteriaceae. This last culture
media was aerobically incubated at 37°C for 24 h, all oth-
ers plates were anaerobically incubated at 37°C for 72 –
96 h.
Immunofluorescence assay for IgA+ cells in small intestine
The tissues (small intestine) from the offspring were pre-
pared for histological studies, fixed in formaldehyde,
dehydrated using a graded series of ethanol and xylene,
and embedded in paraffin following standard methodol-
ogy.
The number of IgA positive cells was determined on his-
tological slices using a direct immunofluorescence assay.
After deparaffinization using xylene and rehydration in a
decreasing gradient of ethanol, paraffin sections (4 μm)
were incubated with a 1:100 dilution of α-chain mono-
specific antibody conjugated with FITC (Sigma, St Louis,
MO, USA) for 30 min and observed with a fluorescent
light microscope. The number of fluorescent cells was
counted in 30 fields at 1000× magnification and results
were expressed as the number of positive fluorescent cells
per ten fields of vision.
Secretory IgA in intestinal fluid
Intestinal fluid was collected from the small intestines of
offspring mice in 1 ml of 0.85% NaCl, centrifuged at 5000
g during 15 min at 4°C, using a refrigerated centrifuge
(Presvac, Buenos Aires, Argentina). The supernatant was
recovered and stored at -20°C until IgA determination.
ELISA was used to measure the concentration of total S-
IgA according to the technique described by LeBlanc et al
[19]. Affinity-purified monoclonal goat anti-IgA (α-chain
specific Sigma, St Louis, MO, USA) was added at 1.25 μg/
well in 0.05 M carbonate-bicarbonate buffer (pH 9.6) to
Costar 96-well, U-bottomed, high-binding polystyrene
microplates (Nunc Inc.) and incubated at 37°C for 1 h.
The plates were then washed three times with PBS con-
taining 0.05% Tween 20 (PBS-T) and blocked for 1 h at
25°C with 0.5% nonfat dry milk in PBS. Plates were
washed five times with PBS-T and incubated for 2 h at
37°C with either 50 μl of standard kappa IgA (Sigma, St.
Louis, USA) or 50 μl samples of intestinal fluid in tripli-
cate. Plates were washed seven times with PBS-T and incu-
bated in the presence of horseradish peroxidase-
conjugated anti-IgA-specific antibodies (Sigma, St. Louis,
MO, USA) at 1.25 μg/well for 1 h at 37°C. Plates were
again washed seven times, and 100 μl of trimethylbenzi-
dine reagent containing peroxide (BD Biosciences, San
Diego, CA, USA) was added to each well. Reactions were
terminated with 100 μl of H2SO4 (2 N) with gentle shak-
ing. The optical density was read at 450 nm using a VERSA
Max Microplate Reader (Molecular Devices, USA).
Determination of macrophage and dendritic cells in 
lamina propria of the small intestine
Macrophages were determined using the BM8 mono-
clonal antibody (Affinity Purified anti-mouse F4/80 Anti-
gen – Pan Macrophage Marker, eBioscience, San Diego,
CA, USA), which reacts with mouse F4/80 antigen. Den-
dritic cells were determined using the 33D1 monoclonal
antibody (Affinity Purified anti-mouse Dendritic Cell
Marker (33D1) eBioscience, San Diego, CA, USA) which
recognizes a mouse dendritic cell-specific surface marker.
The tissues were treated as was previously described. After
deparaffinization, slides from the different groups ana-
lyzed were incubated with a 1:50 dilution of primary anti-
body during 60 min at room temperature. Then the slices
were washed twice in PBS and incubated for 45 min with
a 1:100 dilution of the goat anti-rat antibody conjugated
with FITC (Jackson Immuno Research Labs Inc, West
Grove, USA) at room temperature and washed twice in
PBS. The number of fluorescent cells was counted in 30
fields at 1000× magnification and results were expressed
as the number of positive fluorescent cells per ten fields of
vision.
Determination of goblet cells in small intestine
Slides from the small intestine of the different groups
under study, were deparaffinized and rehydrated in a
decreasing gradient of ethanol and incubated for 150 min
in 1% Alcian Blue 8Gx solution (Merck, Darmstadt, F.R.
Germany) in 3% acetic acid. Histological slides were then
incubated for 6 min in eosin solution and then 40 min in
0.5% safranin solution in 0.1 N HCl. They were then
dehydrated and finally mounted using synthetic Canada
Balsam (Ciccarelli Lab., San Lorenzo, Argentina). Goblet
cells were stained blue with this methodology. The results
are expressed as the number of goblet cells per ten intesti-
nal villous.
Statistical analysis
Statistical analysis were performed using MINITAB 14
software (Minitab, Inc., State College, PA, USA) by
ANOVA GLM followed by a Tukey's posthoc test, and P <
0.05 was considered significant. Unless otherwise indi-
cated, all values (n = 15) were the means of 3 independent
trials (no significant differences were observed between
individual replicates) ± standard deviation (SD).
Results
Effect of the PFM on the intestinal bacterial population 
during development
The results obtained after the administration of PFM to
the mothers during the suckling period or their offspring
after weaning, showed that the most remarkable differ-BMC Immunology 2008, 9:27 http://www.biomedcentral.com/1471-2172/9/27
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ences were found between enterobacteria and bifidoacte-
ria. Mice born from mothers that received PFM during
nursing (group B) showed a significant increase in the
bifidobacteria counts mean log CFU (5.57 ± 0.5 for 12
days and 4.9 ± 0.4 for 21 days; Fig 2) compared with those
from mothers that never received PFM (group A, 3.0 ± 0.1
and 2.3 ± 0.1, respectively for 12 and 21 days). At the
same time, enterobacteria population was increased (3
Intestinal microbiota of the large intestine of newborn mice Figure 2
Intestinal microbiota of the large intestine of newborn mice. The large intestine were aseptically removed, weighed 
and placed into sterile tubes containing peptone water. The samples were immediately homogenized under sterile conditions 
and serial dilutions of the homogenized samples were obtained and aliquots of the appropriate dilution were spread onto the 
surface of following agarized media: Mac Conkey were used for enterobacteria; M-17 for lactic flora; RCA-pH5 for bifidobacte-
ria; MRS for total lactobacilli; RCA total anaerobic bacteria. Colony counts are expressed as log10 numbers of bacteria per gram 
of large intestine. Each point represents the mean of n = 15 ± SD. In order to simplify the analysis of the figure, the statistical 
analysis is showed only for the two media where significant differences were observed (Mac Conkey and RCA-pH5) comparing 
all the groups. a,bMeans for each culture medium without a common letter differ significantly (P < 0.05).BMC Immunology 2008, 9:27 http://www.biomedcentral.com/1471-2172/9/27
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log and 2 log for 12 and 21 days, respectively) in the mice
coming from group B compared with those from group A.
After weaning, mice of group Ba showed a progressive
diminution in the bifidobacteria population, with values
similar to those the control group (Aa). The same was
observed for the enterobacteria comparing these groups of
mice (Fig. 2). In contrast, after 28 days, newborns from
group Ab had higher numbers of bifidobacteria. Reaching
values similar to those of the group that received PFM dur-
ing all the experiment (Bb) and, for this group (Ab),
enterobacteria decreased when bifidobacteria increased
(Fig. 2). At the same period of time, mice from group Bb
had bifidobacteria concentrations similar to the nursing
and the enterobacteria counts diminished significantly
(Fig. 2)
No significant changes were observed for the other bacte-
ria studied comparing different groups; only an increase
of anaerobic bacteria mean log CFU (8.9 ± 1.2) was
observed in the mice from group B at day 12, compared to
mice from group A (6.9 ± 0.1), Fig. 2.
Influence of the PFM administration on IgA+ cells of the 
small intestine and total S-IgA levels
At 12 days of age, the IgA + cells in the small intestine of
the newborn mice did not show significant differences
between newborn mice whose mothers did or did not
receive PFM. At weaning and in the samples on days 28
and 45, newborns from control group (Aa) showed a pro-
gressive increase of IgA+ cells. In contrast, mice from
group B showed a lower count of IgA+ cells at day 28. At
the end of the experiment (45 days) all the groups showed
similar values for these cells (Fig. 3), independent of the
consumption of PFM by the newborns.
At day 12 of age, mice from group B showed a significant
increase of total S-IgA in the intestinal fluid compared to
group A. On day 21 the values decreased in all the groups
with no observable differences among the assayed groups
(Fig. 4). For day 28, the values were the highest in all the
groups; however, no significant differences among each
group were observed. In the adult period (45 days) PFM
did not influence these values (Fig. 4) compared to the
control (Aa).
Influence of PFM consumption on macrophages and 
dendritic cells of lamina propria of small intestine
Macrophages were determined using the BM8 mono-
clonal antibody which reacts with mouse F4/80 antigen, a
transmembrane protein of approximately 125 kDa
expressed by the majority of mature macrophages, which
is currently the best marker for this cell population. The
results obtained for F4/80+ cells showed that PFM con-
sumption by mothers decreased macrophage numbers in
the newborn mice at day 12 in respect to the group with-
out PFM. At 45 days of age (adult mice) all the groups fed
with PFM after weaning (Bb and Ab) showed a significant
increase in the number of cells expressing F4/80 related to
the group Ba and the control group Aa (Table 1).
Dendritic cells were determined using the 33D1 mono-
clonal antibody which recognizes a mouse DC-specific
surface marker. The nature and biological activity of the
33D1 antigen has not yet been elucidated. 33D1 has been
found on a variety of dendritic cell subpopulations from
mouse thymus, spleen, lymph node, and Peyer's patch.
The pattern obtained for dendritic cells was similar to the
macrophages, we observed a decrease in the number of
cells recognized by 33D1 antibody in mice from group B
at day 12 in comparison with group A. At day 45, it was
observed that dendritic cell numbers were increased by
the consumption of the PFM in mice from groups Bb and
Ab (Table 1).
IgA+ cells in the small intestine of newborn mice Figure 3
IgA+ cells in the small intestine of newborn mice. 
IgA+ cells were determined by direct immunofluorescence 
on slides from small intestine of mice of different ages of life 
(12, 21, 28 and 45 days). Results are expressed as number of 
positive cells per 10 fields of vision at 1000× of magnification. 
Values are means for n = 15 ± SD. Mice from each exprimen-
tal group (mice from mother did not received PFM and they 
did not receive PFM (Aa) or they received PFM after weaning 
(Ab); mice from mothers given PFM during suckling period 
and they did not receive PFM (Ba) or they received PFM (Bb) 
after weaning. Means for each value without a common letter 
differ significantly (P < 0.05).BMC Immunology 2008, 9:27 http://www.biomedcentral.com/1471-2172/9/27
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Effect on the nonspecific barrier: goblet cells 
determination
The number of goblet cells decreased in the first sample
(12 days) in newborn mice from group B (Fig. 5). At 21
days of age, both groups of mice reached similar values to
those observed in the control adult mice (65 ± 12, group
Aa). After weaning, on the 28 and the adult age (45 days),
the effect of the consumption of PFM by the offspring was
only observed in the offspring of from mothers that never
received PFM (Ab).
Discussion
The concentration of the bacterial species in the intestinal
tract varied with the age and with the diet of the mice.
There are many reports that showed the relationship
between the administration of fermented milk containing
probiotic bacteria and the increase in Bifidobacterium
numbers [20,21]. This can be related with the recent
observation that some probiotic strains posses metabolic
pathways needed for the synthesis and release of mole-
cules that selectively stimulate the growth of endogenous
bifidobacteria. It has been suggested that the increase in
the concentration of these bacteria could confer a benefi-
cial effect on the stability of the intestinal microbiota [22].
Other reports have demonstrated the beneficial effects of
oral administration of probiotic bacteria on the intestinal
microbiota, especially after antibiotic therapy [23] or in
stress conditions such as malnutrition [24]. Using experi-
mental murine models of malnutrition, it was suggested
that the ingestion of L. casei CRL 431 or conventional
yoghurt was able to restore the gut microbiota [25]. In
these studies either the bacteria or yoghurt were able to
recover the equilibrium between aerobic and anaerobic
strict bacteria. This previous knowledge and the demon-
stration of the immunomodulatory capacity of yoghurt
[26,27] and a fermented milk containing the probiotic
bacteria DN-114001 [13], led us to analyze the effect of a
PFM administered to the mothers during suckling period
or to their offspring (after weaning) on their microbiota
and in some parameters of the gut immune function such
as the nonspecific barrier, IgA+ B lymphocytes, macro-
phages and dendritic cells.
Table 1: Counts of macrophages and dendritic cells of the small 
intestine.
Experimental groups Macrophages Dendritic cells
Nursing
12 days Group A 45 ± 12b 37 ± 12b
Group B 24 ± 7a,c 16 ± 4a
21 days Group A 22 ± 6a,c,d 12 ± 7a,c
Group B 25 ± 8a,c 12 ± 3a,c
Weaning
28 days Group A Aa 22 ± 7a,c,d 9 ± 2c
Ab 14 ± 3d 11 ± 2a,c
Group B Ba 23 ± 7a,c,d 20 ± 7a
Bb 18 ± 4c,d 16 ± 6a,c
45 days Group A Aa 32 ± 6a 14 ± 4a
Ab 72 ± 10e 24 ± 3b
Group B Ba 45 ± 13b 18 ± 2a
Bb 56 ± 10b,e 27 ± 6b
Macrophages and dendritic cells were determined by indirect 
immunofluorescence on the small intestine tissue slides of mice from 
different experimental group (Mother during suckling period without 
PFM (A) or with PFM (B) and offspring after weaning without PFM (a) 
or with PFM (b). Macrophages were determined using the BM8 
monoclonal antibody which reacts with mouse F4/80 antigen and 
dendritic cells were determined using the 33D1 monoclonal antibody 
which recognizes a mouse dendritic cell-specific surface marker.
Results are expressed as number of positive cells recognized for the 
respective primary antibody, counted in 10 fields of vision at 1000× of 
magnification. Values are means for n = 15 ± SD mice from each 
group and at each time point. a,b,c,d,e Means for each cell population 
without a common letter differ significantly (P < 0.05).
S-IgA in the small intestinal fluid of newborn mice Figure 4
S-IgA in the small intestinal fluid of newborn mice. 
ELISA was used to measure the concentration of total S-IgA 
in the small intestine fluid obtained from mice of different 
experimental groups and at different time point. Results are 
expressed as concentration (μg/ml). Each point represents 
the mean of n = 15 ± SD mice from each group (Aa: mother 
and offspring without PFM; Ab: mother without PFM and off-
spring with PFM after weaning; Ba: mother with PFM and off-
spring without PFM after weaning; Bb: mother with PFM and 
offspring with PFM after weaning). In order to simplify the fig-
ure, the statistical analysis is showed only for the first time 
point where significant differences (P < 0.05) were observed 
between mice from groups Ba and Bb and mice from groups 
Aa and Ab. a,b Different letters are used to show the signifi-
cantly differences.BMC Immunology 2008, 9:27 http://www.biomedcentral.com/1471-2172/9/27
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The PFM was selected due to the presence of a probiotic
bacterium and the biological active components pro-
duced during fermentation such as peptides and carbohy-
drates which are able to influence both the indigenous
microbiota and the host immune function. In previous
studies the importance of the nonbacterial fraction from
milk fermented by L. helveticus R389 in the immune stim-
ulation under normal or pathological conditions (intesti-
nal infection, breast cancer) was evaluated [28,29].
In the present work, it was observed that the consumption
of fermented milk containing L. casei DN-114 001, either
by the mother mice during nursing period or by their off-
spring after weaning, influenced the development of the
bifidobacteria population in the large intestine of the
newborn. These increases were accompanied with a
decrease of enterobacteria population (Fig. 2). These find-
ings agree with the results obtained by other authors
where they evaluated the effect of probiotic consumption
on the intestinal microbiota composition: bifidobacteria
were increased and the concentration of enterobacteria
and Clostridium decreased [30,31]. The decrease of this lat-
ter microbial population is desirable since E. coli and
Clostridium  have been implicated in the production of
amonium, aminas and some carcinogens [32]. In con-
trast, many beneficial effects were attributed to bifidobac-
teria [33]. Bifidobacterium  has been related with the
regulation of oral tolerance [34]. With respect to the effect
of the microbiota on the gut immune system, Willliams et
al. [35], reported its effects on the neonatal development
of gut mucosal T cells and myeloid cells in the mouse.
Oral administrations of bifidobacteria strains have shown
immune-enhancing effects [36]. Recent studies indicate
shifts in the composition of the intestinal microbiota
(increased numbers of facultative anaerobes, in conjunc-
tion with a decrease in beneficial organisms such as the
anaerobic lactobacilli and bifidobacteria) were related
with changes of the host's immune system reactivity [37].
In our work, the increase of the bifidobacteria population
observed after PFM ingestion could beneficially affect the
intestinal ecosystem by the many properties attributed to
these bacteria. The immune-modulation effects that have
been observed for bifidobacteria include: increased
mucosal IgA production [38]; stimulation of phagocytic
activity of mononuclear cells [39]; stimulation of natural
killer cells activity [40]; increased lymphocyte responsive-
ness to oral and systemic challenge antigen [41,42]. In this
sense, considering that the consumption of the PFM
increased bifidobacteria population, some immunologi-
cal parameters were measured to analyze the influence of
the development of these bacteria on the regulation of the
immune system.
The IgA+ cells in the lamina propria of the small intestine
were evaluated because Moreau and Gaboriau-Routhiau
[43] reported the importance of the complete microbiota
establishment on the increase of the number of IgA+ cells.
The role of the IgA+ cells in the intestine is undeniable
[44]. The increase in this population was also induced by
oral administration of a suspension of a probiotic bacte-
rium L. casei CRL 431 [45] and by fermented milks such
as yoghurt [27] or the PFM used in the present work when
administered to adult mice [13].
In this study, when the number of IgA+ cells was deter-
mined in the small intestines of newborn mice, it was
observed that PFM administration to their mothers had
no influence during the breast feeding period, compared
to the untreated control (Fig. 3). After weaning (28 and 45
days), newborns from the control group (Aa) showed a
progressive increase of IgA+ cells due to the maturation of
their own adaptative immune system. In contrast, mice
from group B showed a lower count of IgA+ cells at day
28. This last result could be related to the protective effect
provided by the acquisition of the passive immunity
through breast feeding, which was reinforced by the
administration of PFM to their mothers. At the end of the
experiment, when the mice reached maturity, the effect of
the consumption of PFM by the mothers was not
observed; all groups showed similar values for these cells,
independent of the consumption of PFM by the offspring.
During the suckling phase of development, luminal intes-
tinal secretory IgA is provided predominantly by the
colostrum and breast milk, whereas in postweaned mice,
Goblet cells in the small intestine of newborn mice Figure 5
Goblet cells in the small intestine of newborn mice. 
Goblet cells were stained with alcian blue on slides from the 
small intestine of mice from different groups under study. 
Values are means for n = 15 ± SD mice. a,b,c,d,e Means for each 
value without a common letter differ significantly (P < 0.05).BMC Immunology 2008, 9:27 http://www.biomedcentral.com/1471-2172/9/27
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secretory IgA (S-IgA) is synthesized by the weanlings own
adaptive immune system [46,47]. Maternal IgG antibod-
ies enter the fetal circulation through the placenta,
whereas IgA antibodies in milk remain largely within the
human infant's gut where they can influence the intestinal
flora [17].
When the effect of the PFM on the S-IgA was analyzed it
was observed that the animals whose mothers were given
PFM had high levels of total S-IgA in the small intestinal
fluid on day 12 (Fig. 4). This result could be related with
an increase of IgA in the breast milk when the mother con-
sumed PFM. It is believed that maternal antibodies may
have a suppressive effect on the development of mucosal
immune response in their offspring, leading to a partially
developed immune system at weaning [48]. Studies in
mice nursing for a prolonged time have shown a reduced
quantity of IgA in intestinal washing at 5 weeks of age
compared to naturally weaned litters, suggesting an active
role for maternal antibodies in delaying natural IgA
responses [49]. Previous reports showed that the oral
administration of probiotic bacteria suspensions or fer-
mented milk bacteria increased the IgA+ cells in mucosal
tissue distant to the intestine, such as bronchus or mam-
mary glands [50]. At this point of mice development, the
enhancement of S-IgA in milk and consequently in the
gut, could be one of the factors that influence the intesti-
nal microbiota. It was demonstrated that an intact mater-
nal immune system promotes the diversification of the
commensal microbiota in nursing mice depending on the
age and region of the intestine [51].
The lack of increases in the IgA+ cells number and S-IgA in
the small intestine after weaning for mice that received
PFM differ when compared to other results which showed
increases for these parameters when the mice were admin-
istered with the PFM [13]. These results could be related
with the immaturity of the immune system considering
that the previous results were obtained when adult mice
(older than 45 days of age) were used.
Macrophages are an important cell population for the
innate immune response and might also be involved in
the regulation of acquired immune responses as was
reported in the response against mouse hepatitis virus
strain A59 [52]. It was reported that probiotic bacteria can
exert their beneficial properties on the host immune sys-
tem by activating these cells [53]. The marker F4/80 is
present on the surface of a family of cells member of the
mononuclear phagocyte system of mice. The expression of
this antigen can be considered a specialized adaptive state
rather than a separate lineage, which is higher in mature
macrophages and its expression is required for regulatory
T cell development [54].
Dendritic cells are known to be essential immune cells in
innate immunity and in the initiation of adaptive immu-
nity. These cells capture and transfer information from the
outside world to the cells of the adaptive immune system.
They are not only critical for the induction of primary
immune responses, but may also be important for the
induction of immunological tolerance, as well as for the
regulation of the type of T cell-mediated immune
response [55]. It is known that the shaping of adaptive
immunity by innate immunity is dependent on dendritic
cells unique cellular functions and dendritic cell-derived
effector molecules such as cytokines and chemokines
[56]. Intestinal dendritic cells were studied in our model
because they are likely to regulate immunity to gut micro-
biota. IL-10 production by dendritic cells was significantly
increased following stimulation with Bifidobacteria
longum, but not after exposure to lipopolysaccharide or
Streptococcus faecium. Hart et al., [57] studied several pro-
biotic bacteria and showed that they differ in their immu-
nomodulatory activity and influence polarization of
immune responses at the earliest stage of antigen presen-
tation by dendritic cells, being the most marked anti-
inflammatory effects produced by bifidobacteria strains
which up-regulated IL-10 production by dendritic cells. In
this work, the 33D1 antibody was used to study dendritic
cells as is explained in the Results section. The antigen rec-
ognized by 33D1 is an inhibitory receptor and is present
on a subpopulation of dendritic cells. The lack of this
receptor might suggest a gain in function; however, den-
dritic cells recognized by 33D1 are more effective for anti-
gen presentation on the class II major histocompatibility
complex, than on dendritic cells without this receptor
[58]; thus the antigen that binds 33D1 antibody on den-
dritic cells, may reflect their maturation state.
In our study it was determined for both macrophages and
dendritic cells in the lamina propria of the small intestine
that the administration of PFM to the mothers induced a
marked down regulation in their offspring on day 12.
These findings could mean that the offspring would be
protected from the passive immunity provided by the
mother or that the influence of the different microbiota
population favours the down regulation of the immune
cell markers assayed at day 12. This fact would allow a
complete and equilibrated bacterial colonization of the
intestine. An increased activity of the immune cells
involved in phagocytic activity and antigen presentation
would not be beneficial for the host at this time of the
development. This immunoregulatory effect was not
observed in newborn mice from the control group with-
out PFM administration. At day 45, when the mice
reached their maturity and when the microbiota establish-
ment in the intestine was complete, the consumption of
PFM by the mice increased the number of macrophages
and dendritic cells. Results observed for these adult miceBMC Immunology 2008, 9:27 http://www.biomedcentral.com/1471-2172/9/27
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agree with previous studies where the administration of
probiotic bacteria can modulate the immune system and
enhancing receptors related with the maturation of the gut
associated immune cells [53]. These finding could be also
related with other previous reports where the consump-
tion of the PFM by adult mice stimulated the mucosal
immune system with production of cytokines by not only
from T cells but also from macrophages or dendritic cells
[13].
The gastrointestinal epithelium is covered by a protective
mucus containing predominantly mucin glycoproteins
that are synthesized and secreted by goblet cells. Intestinal
microbes may directly affect goblet cell functions through
the local release of bioactive factors. Alternatively, goblet
cell functions may be altered in response to host-derived
bioactive factors generated by activated epithelial or
underlying lamina propria cells after their contact with
intestinal bacteria [59]. The concept of the mucus layer
functioning as a dynamic defensive barrier is suggested by
studies showing altered mucus-related indexes in germ-
free animals [60,61] and from consistent evidence of
enhanced mucus secretion in response to intestinal
microbes [62].
The number of goblet cells in the groups of mice whose
mothers received PFM during nursing decreased only in
the first sample (12 days, Fig. 5); after which this cell pop-
ulation reached values similar to the control and main-
taining them during all the experiment (independent of
the consumption of PFM after weaning). After weaning,
the effect of the consumption of PFM by the offspring was
observed only in the mice from mothers that never
received PFM (Ab). The observation that mice from moth-
ers that received PFM did not show increases in these cells
could be related with the passive immunity provide by the
maternal immune system reinforced for the consumption
of the PFM by their mothers as was explained for IgA+
cells.
The present work showed a postnatal modulation of the
intestinal microbiota of the offspring influenced by con-
sumption of fermented milk containing L. casei DN-
114001 by their mothers during nursing and by the off-
spring after weaning. The administration of this fer-
mented milk to the mothers during nursing improved
their own immune system (as was reported previously in
adult mice feeding with this PFM, [13]) and this was
reflected in their offspring. The consumption of the PFM
by the mothers or their offspring favored the growth of
bifidobacteria which are related with the improvement of
the gut immune system of the offspring. The down regu-
lation observed during the suckling period could be
related with the improvement of the immunity of the
mother fed with the PFM, which passively protect the
babies in this important period of their life. At weaning
and one week afterwards is a critical period that could be
compared to the first years of human babies where the
immune system is maturing and it is desirable that the
administration of a probiotic microorganism does not
alter early innate immune responses in this population at
high risk of developing allergic diseases [63]. At day 45,
the mice reach the maturity of their own immune system
and the effects observed in the mice that received PFM
agree with previous works where adult mice were used
and the PFM stimulated their mucosal immunity.
Increases for secretory IgA of the babies was another tool
by which the beneficial effect of PFM administration to
the mother during breast feeding period can be explained.
Conclusion
The main contribution of this work is the demonstration
that the administration of a specific probiotic fermented
milk during nursing has beneficial impact on the microbi-
ota development of the nursing offspring and this was
related with a modulation of two important immune cell
populations (macrophages and dendritic cells) that are
involved in both innate and acquired immunity.
The present work shows the beneficial effect of the admin-
istration of a probiotic fermented milk, not only to the
mothers during the suckling period, but also to the off-
spring near and after weaning and in the adulthood where
the immune system is matured and there are many reports
about the beneficial effects of the probiotics on the immu-
nity of the host. This effect was due to the improved bal-
ances of the intestinal microbiota which are related with a
modulation of the intestinal immune response, which
was observed with the stimulation of the IgA + cells, mac-
rophages and dendritic cells.
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